Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of chemotherapy, radiation therapy, and gefitinib in patients with Stage III non-small cell lung cancer has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Adenosquamous Cell Carcinoma of the Lung
• Bronchioloalveolar Carcinoma of the Lung
• Large Cell Carcinoma of the Lung
• Non-small Cell Lung Cancer Stage Iiia
• Non-small Cell Lung Cancer Stage Iiib
• Squamous Cell Carcinoma of the Lung

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer | Phase 2 | Status: COMPLETED